Novamind is well capitalized to grow its network of outpatient mental health clinics and clinical research sites, both organically and through acquisitions, with the goal of expanding patient access to alternative mental health treatments, including psychedelic-assisted psychotherapy.” “The close of this $10 million round and our anticipated CSE listing are important milestones that will enable us to execute our business plan from a position of strength. “The overwhelming support from new and existing shareholders and the interest we received from institutional and retail investors are a testament to the strength of our team, our business model and our opportunities for growth,” said Yaron Conforti, Chief Executive Officer and Director of Novamind. With this latest round, Novamind has raised a total of CAD$15.3 million since its inception in 2019. (“ Hinterland“) and Novamind Ventures Inc. (“ Novamind” or the “ Company“), a leading mental health and wellness company specialized in psychedelic-assisted psychotherapy, today announced that Novamind has closed an oversubscribed private placement of subscription receipts (the “ Financing“), raising aggregate gross proceeds of CAD$10.0 million, twice the original CAD$5.0 million target.
#NOVAMIND WINDOWS 10 KEYGEN#
TORONTO, ON / ACCESSWIRE / Novem/ Hinterland Metals Inc.
Any failure to comply with this restriction may constitute a violation of U.S. newswire services or for dissemination in the United States.
Anticipates trading on CSE under ticker symbol “NM” upon completion of RTO.
0 kommentar(er)
